Structural and kinetic features of amyloid beta-protein fibrillogenesis. (Q47758213)

5 February 2018

review article

1 reference

title

Structural and kinetic features of amyloid beta-protein fibrillogenesis. (English)

1 reference

5 February 2018

author name string

Teplow DB

series ordinal

1

1 reference

5 February 2018

publication date

1 June 1998

1 reference

5 February 2018

published in

Amyloid

1 reference

5 February 2018

volume

5

1 reference

5 February 2018

page(s)

121-142

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The spectrum of behavioral changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The molecular pathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Differential diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Therapeutic approaches related to amyloid-beta peptide and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The family caregiver's role in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The economic burden of Alzheimer's disease care

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Structural characterization of the core of the paired helical filament of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Alzheimer's disease: genotypes, phenotypes, and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Amyloid, the presenilins and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Alzheimer's disease: a central role for amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The Alzheimer family of diseases: many etiologies, one pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

New clues to Alzheimer's disease: unraveling the roles of amyloid and tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Anti-amyloid drugs: potential in the treatment of diseases associated with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

21 January 2018

Conformational disease

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Ultrastructural characterization of cerebellar diffuse plaques in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Differences between vascular and plaque core amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Neuritic plaque amyloid in Alzheimer's disease is highly racemized

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Characterization of beta-amyloid peptide from human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Alzheimer's soluble amyloid beta is a normal component of human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Neuritic pathology and dementia in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Correlations of synaptic and pathological markers with cognition of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Two distinct ubiquitin immunoreactive senile plaques in Alzheimer's disease: relationship with the intellectual status in 29 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

High-resolution electron microscopic analysis of the amyloid fibril

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Morphology and antibody recognition of synthetic beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

pH-dependent structural transitions of Alzheimer amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Structural analysis of Alzheimer's beta(1-40) amyloid: protofilament assembly of tubular fibrils.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Configurations of Polypeptide Chains With Favored Orientations Around Single Bonds: Two New Pleated Sheets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

"Cross-beta" conformation in proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Conformation of twisted β-pleated sheets in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

New domain motif: the structure of pectate lyase C, a secreted plant virulence factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Comparative analysis of human and Dutch-type Alzheimer beta-amyloid peptides by infrared spectroscopy and circular dichroism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Racemization: its biological significance on neuropathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Solution structure of residues 1-28 of the amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The C-terminus of the beta protein is critical in amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral haemorrhage with amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Solid-state NMR studies of the prion protein H1 fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Kinetics of aggregation of synthetic beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Two conformational states of amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Solvent effects on self-assembly of beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

A biotechnological method provides access to aggregation competent monomeric Alzheimer's 1-42 residue amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Experimental attempt to simulate receptor site environment. A 500-MHz 1H nuclear magnetic resonance study of enkephalin amides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Kinetic theory of fibrillogenesis of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Soluble multimeric Alzheimer beta(1-40) pre-amyloid complexes in dilute solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Transthyretin sequesters amyloid beta protein and prevents amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Enhanced aggregation and beta structure of amyloid beta peptide after coincubation with C1q.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Laminin inhibits amyloid-beta-peptide fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

The interaction between Alzheimer amyloid beta(1-40) peptide and ganglioside GM1-containing membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Aggregation of amyloid beta-protein and its neurotoxicity: enhancement by aluminum and other metals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Examination of the Structure of the Transthyretin Amyloid Fibril by Image Reconstruction from Electron Micrographs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Transthyretin amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Specific proteoglycans as potential causative agents and relevant targets for therapeutic intervention in Alzheimer's disease and other amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129808995290

10.3109/13506129808995290

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9686307

1 reference

5 February 2018